Evidence map›Paper›PMID 40102267›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Grey matter morphometry in young adult e-cigarette users, tobacco cigarette users & non-using controls.

Kanwar Boparai, Hsiang-Yuan Lin, Peter Selby, Laurie Zawertailo

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kanwar BoparaiINTREPID Lab, IMHPR, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON, M6J 1H4, Canada.
Hsiang-Yuan LinAzrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON, M6J 1H4, Canada.ORCID http://orcid.org/0000-0001-9519-209X
Peter SelbyINTREPID Lab, IMHPR, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON, M6J 1H4, Canada.
Laurie ZawertailoINTREPID Lab, IMHPR, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, ON, M6J 1H4, Canada. laurie.zawertailo@camh.ca.

Funding

Canadian Cancer Society Research Institute (Société Canadienne du Cancer) 707321-1
6 · The paper itself

Abstract

Despite the rise in electronic cigarette use in recent years, the neurobiological effects of daily e-cigarette use versus smoking cigarettes in young adults remains unknown. This study aimed to investigate the impact of regular, exclusive e-cigarette use on grey matter morphometry in young adults, age 18-25. Structural MRI data were collected from 3 distinct groups of participants (n = 78): daily, exclusive e-cigarette users; tobacco cigarette users; and non-using controls, to assess grey matter volume (GMV) differences. Voxel-based morphometry revealed significant GMV reductions in tobacco cigarette users in the left fusiform gyrus (FG), left and right inferior temporal gyrus (IFG), right middle temporal gyri, and right middle cingulate gyrus (MCG), compared to controls, as well as the anterior cingulate cortex (ACC), compared to both e-cigarette users and controls, even after adjusting for nicotine exposure history. Partial correlation analyses revealed that in tobacco cigarette users, GMV in the FG, ITG, MTG, and MCG displayed a strong, negative association with exposure history but not with nicotine dependence. GMV of the ACC was not associated with duration of use or nicotine dependence score, suggesting distinct relationships between ACC volume and smoking status and FG/ITG/MTG/MCG volume and smoking status. This indicates a distinct difference between regular tobacco cigarette and e-cigarette use, perhaps a relatively safer profile of e-cigarette use on GMV. These findings suggest that factors beyond nicotine, such as other toxicants in tobacco cigarette smoke, may contribute to the observed brain atrophy, or imply potential pre-existing vulnerabilities that might predispose individuals to take up smoking.

Indexed as

BrainCigarette SmokingElectronic Nicotine Delivery SystemsGray MatterVapingAdolescentAdultFemaleHumansMagnetic Resonance ImagingMaleTobacco Use DisorderYoung Adult

Identifiers

PMID40102267
PMCPMC12259977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.